Commensal microbes and sexual dimorphism in autoimmunity

自身免疫中的共生微生物和性别二态性

基本信息

  • 批准号:
    8828075
  • 负责人:
  • 金额:
    $ 23.14万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2014
  • 资助国家:
    美国
  • 起止时间:
    2014-04-01 至 2017-03-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Many of major autoimmune diseases are sexually dimorphic. Systemic Lupus Erythematosus (SLE), scleroderma, multiple sclerosis, Sjogren's syndrome, autoimmune diseases of thyroid gland and others are primarily occurring in females. In a mouse model of spontaneous type 1 diabetes (T1D in non-obese diabetic, NOD, mice) the disease is stronger in females. A survey of NOD colonies around the world found that not only overall incidence of T1D varied greatly between different facilities, but that the female/male incidence ratio varied. The variability suggests that some factors that cannot be easily accounted for clearly affect the disease progression. In other facilities, including ours, the incidence in males is even lower (about 15-20% at 30 wks), whereas the incidence in females is around 65-80%. As a part of the studies of the role of microbial environment on T1D development, we have rederived NOD mice into germ-free (sterile) conditions. We realized that these mice no longer showed sexual dimorphism! That means that the hormones (clearly shown to be involved) and the microbiota are interacting in some way that affects the disease progression. Our main hypothesis suggests that the hormones and microbial products act together (dual-signal hypothesis) to induce tolerance to T1D in males. Preliminary analysis has revealed a role for Interferon-gamma in protection of males from T1D. It is proposed to test the hypothesis by a variety of approaches including colonization of germ-free mice with defined microbiota, genetic approach and gene expression analysis. We will also to test whether systemic immunity in a common genetically complex mouse model of SLE is also sexually dimorphic because of the presence of microbes. Accordingly, two specific aims are: Specific Aim 1. Investigate the effector mechanisms that make NOD males more resistant to T1D. We will test the role of specific microbial lineages in controlling sexual dimorphism; we will study te signaling pathway and cell types involved in tolerance induction using gene-expression and genetic approaches. We will study how manipulations of sex hormones affect microbial composition and functions; we will use gene expression analysis to delineate signaling pathways important for hormone-dependent control over microbiota. Specific Aim 3. Investigate whether sexual dimorphism in a mouse model of SLE is dependent on microbes. We will study the role of microbiota in induction and sexual dimorphism in NZBWF1 mice in germ-free environment.
描述(由申请人提供):许多主要的自身免疫性疾病是性二态性的。系统性红斑狼疮(SLE)、硬皮病、多发性硬化症、干燥综合征、甲状腺自身免疫性疾病等主要发生在女性中。在自发性1型糖尿病小鼠模型(非肥胖糖尿病NOD小鼠的T1 D)中,雌性小鼠的疾病更严重。对世界各地NOD群体的调查发现,不仅T1 D的总体发病率在不同设施之间差异很大,而且女性/男性发病率也各不相同。这种变异性表明,一些不能轻易解释的因素明显影响疾病进展。在其他机构,包括我们的机构,男性的发病率甚至更低(30周时约为15-20%),而女性的发病率约为65- 80%。作为研究微生物环境对T1 D发展的作用的一部分,我们将NOD小鼠重新衍生为无菌(无菌)条件。我们意识到这些老鼠不再表现出两性异形!这意味着激素(清楚地表明参与其中)和微生物群以某种方式相互作用,影响疾病的进展。我们的主要假设表明,激素和微生物产物共同作用(双信号假说),以诱导耐受T1 D的男性。初步分析揭示了干扰素-γ在保护男性免受T1 D中的作用。建议通过多种方法来检验这一假设,包括用确定的微生物群定殖无菌小鼠、遗传方法和基因表达分析。我们还将测试在一个常见的遗传复杂的SLE小鼠模型中的系统免疫是否也由于微生物的存在而具有性二态性。因此,有两个具体目标:具体目标1。研究使NOD男性对T1 D更具抵抗力的效应机制。我们将测试特定微生物谱系在控制性二态性中的作用;我们将使用基因表达和遗传方法研究参与耐受性诱导的信号通路和细胞类型。我们将研究性激素的操纵如何影响微生物的组成和功能;我们将使用基因表达分析来描绘对微生物群依赖性控制重要的信号通路。具体目标3。研究SLE小鼠模型的两性异形是否依赖于微生物。我们将在无菌环境中研究微生物群在NZBWF 1小鼠诱导和性二型性中的作用。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ALEXANDER V CHERVONSKY其他文献

ALEXANDER V CHERVONSKY的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ALEXANDER V CHERVONSKY', 18)}}的其他基金

Enhancement of autoimmunity in type 1 diabetes by gluten
麸质增强 1 型糖尿病的自身免疫能力
  • 批准号:
    10390844
  • 财政年份:
    2021
  • 资助金额:
    $ 23.14万
  • 项目类别:
Enhancement of autoimmunity in type 1 diabetes by gluten
麸质增强 1 型糖尿病的自身免疫能力
  • 批准号:
    10490911
  • 财政年份:
    2021
  • 资助金额:
    $ 23.14万
  • 项目类别:
Enhancement of autoimmunity in type 1 diabetes by gluten
麸质增强 1 型糖尿病的自身免疫能力
  • 批准号:
    10680525
  • 财政年份:
    2021
  • 资助金额:
    $ 23.14万
  • 项目类别:
Host's and microbiota's contribution to sexual dimorphism of autoimmunity
宿主和微生物群对自身免疫性二态性的贡献
  • 批准号:
    9388410
  • 财政年份:
    2017
  • 资助金额:
    $ 23.14万
  • 项目类别:
Host's and microbiota's contribution to sexual dimorphism of autoimmunity
宿主和微生物群对自身免疫性二态性的贡献
  • 批准号:
    10216963
  • 财政年份:
    2017
  • 资助金额:
    $ 23.14万
  • 项目类别:
Host's and microbiota's contribution to sexual dimorphism of autoimmunity
宿主和微生物群对自身免疫性二态性的贡献
  • 批准号:
    10608647
  • 财政年份:
    2017
  • 资助金额:
    $ 23.14万
  • 项目类别:
Diet and microbiota in type 1 diabetes
1 型糖尿病的饮食和微生物群
  • 批准号:
    8815476
  • 财政年份:
    2014
  • 资助金额:
    $ 23.14万
  • 项目类别:
Commensal microbes and sexual dimorphism in autoimmunity
自身免疫中的共生微生物和性别二态性
  • 批准号:
    8643918
  • 财政年份:
    2014
  • 资助金额:
    $ 23.14万
  • 项目类别:
Intravital Imaging of Type I Diabetes
I 型糖尿病的活体成像
  • 批准号:
    8114678
  • 财政年份:
    2011
  • 资助金额:
    $ 23.14万
  • 项目类别:
Intravital Imaging of Type I Diabetes
I 型糖尿病的活体成像
  • 批准号:
    8690037
  • 财政年份:
    2011
  • 资助金额:
    $ 23.14万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 23.14万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 23.14万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 23.14万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 23.14万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 23.14万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 23.14万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 23.14万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 23.14万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 23.14万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 23.14万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了